Point72 Asset Management
ACET icon

Point72 Asset Management’s Adicet Bio ACET Stock Holding History

Point72 Asset Management’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,104
Closed -$102K – 2110
2023
Q1 		$102K Buy
1,104
+1,085
+5,711% +$136K ﹤0.01% 1626
2022
Q4 		$2.68K Sell
19
-7,096
-100% -$1.77M ﹤0.01% 1420
2022
Q3 		$1.62M Sell
7,115
-691
-9% -$175K 0.01% 975
2022
Q2 		$1.82M Sell
7,806
-17,076
-69% -$3.75M 0.01% 956
2022
Q1 		$7.95M Sell
24,882
-25,362
-50% -$5.83M 0.03% 577
2021
Q4 		$14.1M Sell
50,244
-29,444
-37% -$5.05M 0.06% 419
2021
Q3 		$10M Buy
79,688
+3,750
+5% +$465K 0.04% 490
2021
Q2 		$12.5M Buy
75,938
+10,432
+16% +$2.12M 0.06% 394
2021
Q1 		$13.7M Buy
+65,506
New +$15M 0.06% 350

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Point72 Asset Management's ACET Position: Q2 2023 in Review

Point72 Asset Management sold out of Adicet Bio (ACET) in Q2 2023, closing a stake of 1,104 shares — an estimated $102K sold.

Point72 Asset Management first reported a position in ACET in Q1 2021 and held it in 9 quarters. The position peaked at $14.1M in Q4 2021. 94 funds tracked by Wall St. Rank hold ACET as of Q2 2023.

  • Point72 Asset Management reported no remaining Adicet Bio position as of Q2 2023 after selling out during the quarter.
  • Point72 Asset Management sold 1,104 Adicet Bio shares in Q2 2023, an estimated $102K.
  • Point72 Asset Management first reported a position in Adicet Bio in Q1 2021 and held it in 9 quarters.
  • Point72 Asset Management's Adicet Bio position peaked at $14.1M in Q4 2021.
  • 94 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2023.

Based on Point72 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.